secukinumab   Click here for help

GtoPdb Ligand ID: 8078

Synonyms: AIN 457 | AIN457 | Cosentyx® | NVP-AIN457
Approved drug Immunopharmacology Ligand
secukinumab is an approved drug (Japan (2014), FDA and EMA (2015))
Compound class: Antibody
Comment: Peptide sequences for this antibody are available from its IMGT/mAb-DB entry.
This antibody is the subject of patent US7807155 [2].
Immunopharmacology Disease
Disease X-Refs Comment References
Psoriasis Disease Ontology: DOID:8893
 Approved therapeutic for plaque psoriasis.
Rheumatoid arthritis Disease Ontology: DOID:7148
OMIM: 180300
 Phase 3 study in RA was terminated (see NCT01770379).
Ankylosing spondylitis Disease Ontology: DOID:7147
 Approved therapeutic for ankylosing spondylitis.
Psoriatic arthritis Disease Ontology: DOID:9008
 Approved therapeutic for PsA.